The Prognostic Value of Normal Exercise Myocardial Perfusion Imaging and Exercise Echocardiography. A Meta-Analysis

Journal of the American College of Cardiology

Volumn 49, Issue 2, 2007, Pages 227-237

  Metz, Louise D ^a   Beattie, Mary ^b   Hom, Robert ^b   Redberg, Rita F ^b   Grady, Deborah ^b,c   Fleischmann, Kirsten E ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; ECHOCARDIOGRAPHY; EXERCISE ECHOCARDIOGRAPHY; EXERCISE MYOCARDIAL PERFUSION IMAGING; FEMALE; FOLLOW UP; HEART DEATH; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; MALE; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; SYSTEMATIC REVIEW; UNSTABLE ANGINA PECTORIS;

AGE FACTORS; AGED; COHORT STUDIES; CORONARY DISEASE; ECHOCARDIOGRAPHY, STRESS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX FACTORS; SURVIVAL ANALYSIS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33845988371     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.08.048     Document Type: Article

References (169)

1. Diamond G.A., and Forrester J.S. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med 300 (1979) 1350-1358
2. Brown K.A. Prognostic value of thallium-201 myocardial perfusion imaging. A diagnostic tool comes of age. Circulation 83 (1991) 363-381
3. Brown K.A. Prognostic value of cardiac imaging in patients with known or suspected coronary artery disease: comparison of myocardial perfusion imaging, stress echocardiography, and position emission tomography. Am J Cardiol 75 (1995) 35D-41D
4. Brown K.A., Rosman D.R., and Dave R.M. Stress nuclear myocardial perfusion imaging versus stress echocardiography: prognostic comparisons. Prog Cardiovasc Dis 43 (2000) 231-244
5. Geleijnse M.L., and Elhendy A. Can stress echocardiography compete with perfusion scintigraphy in the detection of coronary artery disease and cardiac risk assessment?. Eur J Echocardiogr 1 (2000) 12-21
6. Bonow R.O. Diagnosis and risk stratification in coronary artery disease: nuclear cardiology versus stress echocardiography. J Nucl Cardiol 4 (1997) S172-S178
7. Rozanski A., and Gottdiener J.S. Stress radionuclide imaging versus stress echocardiography: a framework for comparisons. Prog Cardiovasc Dis 43 (2001) 275-279
8. Marwick T.H. Use of stress echocardiography for the prognostic assessment of patients with stable chronic coronary artery disease. Eur Heart J 18 Suppl D (1997) D97-D101
9. Marwick T.H. Stress echocardiography. Heart 89 (2003) 113-118
10. Mark D.B., Hlatky M.A., Harrell Jr. F.E., Lee K.L., Califf R.M., and Pryor D.B. Exercise treadmill score for predicting prognosis in coronary artery disease. Ann Intern Med 106 (1987) 793-800
11. Mark D.B., Shaw L., Harrell Jr. F.E., et al. Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med 325 (1991) 849-853
12. Morris C.K., Ueshima K., Kawaguchi T., Hideg A., and Froelicher V.F. The prognostic value of exercise capacity: a review of the literature. Am Heart J 122 (1991) 1423-1431
13. Kwok Y., Kim C., Grady D., Segal M., and Redberg R. Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 83 (1999) 660-666
14. Begg C.B., and Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 50 (1994) 1088-1101
15. Hosie C.J., Rodger J.C., and Railton R. The value of thallium scintigraphy in a district general hospital. Nucl Med Commun 14 (1993) 12-14
16. Lee D.S., Jang M.J., Cheon G.J., Chung J.K., and Lee M.C. Comparison of the cost-effectiveness of stress myocardial SPECT and stress echocardiography in suspected coronary artery disease considering the prognostic value of false-negative results. J Nucl Cardiol 9 (2002) 515-522
17. Daly C., Norrie J., Murdoch D.L., Ford I., Dargie H.J., and Fox K. The value of routine non-invasive tests to predict clinical outcome in stable angina. Eur Heart J 24 (2002) 532-540
18. Miller T.D., Roger V.L., Milavetz J.J., et al. Assessment of the exercise electrocardiogram in women versus men using tomographic myocardial perfusion imaging as the reference standard. Am J Cardiol 87 (2001) 868-873
19. Hachamovitch R., Hayes S.W., Friedman J.D., Cohen I., and Berman D.S. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 107 (2003) 2900-2907
20. Garcia M.J., Neumann D., Go R.T., et al. Comparison of persistent thallium perfusion defects by quantitative washout analysis with thallium reinjection in patients with coronary artery disease. Am J Cardiol 74 (1994) 977-981
21. Pollock S.G., Abbott R.D., Boucher C.A., Beller G.A., and Kaul S. Independent and incremental prognostic value of tests performed in hierarchical order to evaluate patients with suspected coronary artery disease. Validation of models based on these tests. Circulation 85 (1992) 237-248
22. Gibson P.B., Demus D., Noto R., Hudson W., and Johnson L.L. Low event rate for stress-only perfusion imaging in patients evaluated for chest pain. J Am Coll Cardiol 39 (2002) 999-1004
23. Nallamothu N., Pancholy S.B., Lee K.R., Heo J., and Iskandrian A.S. Impact on exercise single-photon emission computed tomographic thallium imaging on patient management and outcome. J Nucl Cardiol 2 (1995) 334-338
24. Sharir T., Germano G., Kavanagh P.B., et al. Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation 100 (1999) 1035-1042
25. Obeidat O., Arida M., Al-Mallah M., Alam M., and Ananthasubramaniam K. Segmental early relaxation phenomenon: incidence, clinical characteristics, and significance in stress echocardiography. Chest 125 (2004) 1218-1223
26. Hayes S.W., De Lorenzo A., Hachamovitch R., et al. Prognostic implications of combined prone and supine acquisitions in patients with equivocal or abnormal supine myocardial perfusion SPECT. J Nucl Med 44 (2003) 1633-1640
27. Poornima I.G., Miller T.D., Christian T.F., Hodge D.O., Bailey K.R., and Gibbons R.J. Utility of myocardial perfusion imaging in patients with low-risk treadmill scores. J Am Coll Cardiol 43 (2004) 194-199
28. Worthley M.I., Unger S.A., Mathew T.H., Russ G.R., and Horowitz J.D. Usefulness of tachycardic-stress perfusion imaging to predict coronary artery disease in high-risk patients with chronic renal failure. Am J Cardiol 92 (2003) 1318-1320
29. Candell-Riera J., Oller-Martinez G., Pereztol-Valdes O., et al. Usefulness of myocardial perfusion SPECT in patients with left bundle branch block and previous myocardial infarction. Heart 89 (2003) 1039-1042
30. Lapeyre III A.C., Poornima I.G., Miller T.D., Hodge D.O., Christian T.F., and Gibbons R.J. Prognostic value of exercise stress myocardial perfusion imaging in patients with permanent pacemakers. Am J Cardiol 94 (2004) 811-814
31. Elhendy A., Schinkel A.F., van Domburg R.T., Bax J.J., and Poldermans D. Incidence and predictors of heart failure during long-term follow-up after stress Tc-99m sestamibi tomography in patients with suspected coronary artery disease. J Nucl Cardiol 11 (2004) 527-533
32. Kamalesh M., Matorih R., and Sawada S. Comparative prognostic significance of transesophageal versus transthoracic echocardiography. Echocardiography 19 (2002) 313-318
33. Font V.E., Lara W.C., and Bournigal D.R. Stress echocardiography for predicting cardiac events in octogenarians: is myocardial perfusion scintigraphy necessary anymore?. South Med J 89 (1996) 1166-1173
34. Groutars R.G., Verzijlbergen J.F., Muller A.J., et al. Prognostic value and quality of life in patients with normal rest thallium-201/stress technetium 99m-tetrofosmin dual-isotope myocardial SPECT. J Nucl Cardiol 7 (2000) 333-341
35. Dodi C., Cortigiani L., Masini M., Olivotto I., Azzarelli A., and Nannini E. The incremental prognostic value of pharmacological stress echo over exercise electrocardiography in women with chest pain of unknown origin. Eur Heart J 22 (2001) 145-152
36. Machecourt J., Longere P., Fagret D., et al. Prognostic value of thallium-201 single-photon emission computed tomographic myocardial perfusion imaging according to extent of myocardial defect. Study in 1,926 patients with follow-up at 33 months. J Am Coll Cardiol 23 (1994) 1096-1106
37. Giri S., Shaw L.J., Murthy D.R., et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 105 (2002) 32-40
38. Marwick T.H., Case C., Sawada S., Vasey C., and Thomas J.D. Prediction of outcomes in hypertensive patients with suspected coronary artery disease. Hypertension 39 (2002) 1113-1118
39. Marwick T.H., Case C., Sawada S., Vasey C., Short L., and Lauer M. Use of stress echocardiography to predict mortality in patients with diabetes and known or suspected coronary artery disease. Diabetes Care 25 (2002) 1042-1048
40. Shaw L.J., Miller D.D., Romeis J.C., Kargl D., Younis L.T., and Chaitman B.R. Gender differences in the noninvasive evaluation and management of patients with suspected coronary artery disease. Ann Intern Med 120 (1994) 559-566
41. Davar J.I., Roberts E.B., Coghlan J.G., Evans T.R., and Lipkin D.P. Prognostic value of stress echocardiography in women with high (> or = 80%) probability of coronary artery disease. Postgrad Med J 77 (2001) 573-577
42. Yao S.S., Qureshi E., Syed A., and Chaudhry F.A. Novel stress echocardiographic model incorporating the extent and severity of wall motion abnormality for risk stratification and prognosis. Am J Cardiol 94 (2004) 715-719
43. Travin M.I., Heller G.V., Johnson L.L., et al. The prognostic value of ECG-gated SPECT imaging in patients undergoing stress Tc-99m sestamibi myocardial perfusion imaging. J Nucl Cardiol 11 (2004) 253-262
44. Lima R.S., De Lorenzo A., Pantoja M.R., and Siqueira A. Incremental prognostic value of myocardial perfusion 99m-technetium-sestamibi SPECT in the elderly. Int J Cardiol 93 (2004) 137-143
45. Leslie W.D., Tully S.A., Yogendran M.S., Ward L.M., Nour K.A., and Metge C.J. Prognostic value of automated quantification of 99mTc-sestamibi myocardial perfusion imaging. J Nucl Med 46 (2005) 204-211
46. Elhendy A., Schinkel A.F., van Domburg R.T., Bax J.J., Valkema R., and Poldermans D. Prediction of all-cause mortality in women with known or suspected coronary artery disease by stress technetium-99m tetrofosmin myocardial perfusion imaging. Am J Cardiol 93 (2004) 450-452
47. Thomas G.S., Miyamoto M.I., Morello III A.P., et al. Technetium 99m sestamibi myocardial perfusion imaging predicts clinical outcome in the community outpatient setting: the Nuclear Utility in the Community (NUC) study. J Am Coll Cardiol 43 (2004) 213-223
48. Groutars R.G., Verzijlbergen J.F., Zwinderman A.H., et al. Incremental prognostic value of myocardial SPET with dual-isotope rest (201)Tl/stress (99m)Tc-tetrofosmin. Eur J Nucl Med Mol Imaging 29 (2002) 46-52
49. Elhendy A., Schinkel A.F., van Domburg R.T., et al. Risk stratification of patients with angina pectoris by stress 99mTc-tetrofosmin myocardial perfusion imaging. J Nucl Med 46 (2005) 2003-2008
50. Syed M.A., Al-Malki Q., Kazmouz G., et al. Usefulness of exercise echocardiography in predicting cardiac events in an outpatient population. Am J Cardiol 82 (1998) 569-573
51. Miller T.D., Christian T.F., Clements I.P., Hodge D.O., Gray D.T., and Gibbons R.J. Prognostic value of exercise thallium-201 imaging in a community population. Am Heart J 135 (1998) 663-670
52. Steinberg E.H., Koss J.H., Lee M., Grunwald A.M., and Bodenheimer M.M. Prognostic significance from 10-year follow-up of a qualitatively normal planar exercise thallium test in suspected coronary artery disease. Am J Cardiol 71 (1993) 1270-1273
53. Hachamovitch R., Berman D.S., Kiat H., et al. Effective risk stratification using exercise myocardial perfusion SPECT in women: gender-related differences in prognostic nuclear testing. J Am Coll Cardiol 28 (1996) 34-44
54. Heupler S., Mehta R., Lobo A., Leung D., and Marwick T.H. Prognostic implications of exercise echocardiography in women with known or suspected coronary artery disease. J Am Coll Cardiol 30 (1997) 414-420
55. Shaw L.J., Miller D.D., Romeis J.C., et al. Prognostic value of noninvasive risk stratification in younger and older patients referred for evaluation of suspected coronary artery disease. J Am Geriatr Soc 44 (1996) 1190-1197
56. Marie P.Y., Danchin N., Durand J.F., et al. Long-term prediction of major ischemic events by exercise thallium-201 single-photon emission computed tomography. Incremental prognostic value compared with clinical, exercise testing, catheterization and radionuclide angiographic data. J Am Coll Cardiol 26 (1995) 879-886
57. Marwick T.H., Case C., Vasey C., Allen S., Short L., and Thomas J.D. Prediction of mortality by exercise echocardiography: a strategy for combination with the duke treadmill score. Circulation 103 (2001) 2566-2571
58. Marwick T.H., Mehta R., Arheart K., and Lauer M.S. Use of exercise echocardiography for prognostic evaluation of patients with known or suspected coronary artery disease. J Am Coll Cardiol 30 (1997) 83-90
59. Marwick T.H., Shaw L.J., Lauer M.S., et al., Economics of Noninvasive Diagnosis (END) Study Group. The noninvasive prediction of cardiac mortality in men and women with known or suspected coronary artery disease. Am J Med 106 (1999) 172-178
60. Shaw L.J., Hachamovitch R., Heller G.V., et al., The Economics of Noninvasive Diagnosis (END) Study Group. Noninvasive strategies for the estimation of cardiac risk in stable chest pain patients. Am J Cardiol 86 (2000) 1-7
61. Diaz L.A., Brunken R.C., Blackstone E.H., Snader C.E., and Lauer M.S. Independent contribution of myocardial perfusion defects to exercise capacity and heart rate recovery for prediction of all-cause mortality in patients with known or suspected coronary heart disease. J Am Coll Cardiol 37 (2001) 1558-1564
62. Cohen Y., Acio E., Heo J., Hughes E., Narula J., and Iskandrian A.E. Comparison of the prognostic value of qualitative versus quantitative stress tomographic perfusion imaging. Am J Cardiol 83 (1999) 945-948
63. Snader C.E., Marwick T.H., Pashkow F.J., Harvey S.A., Thomas J.D., and Lauer M.S. Importance of estimated functional capacity as a predictor of all-cause mortality among patients referred for exercise thallium single-photon emission computed tomography: report of 3,400 patients from a single center. J Am Coll Cardiol 30 (1997) 641-648
64. Marwick T.H., Case C., Short L., and Thomas J.D. Prediction of mortality in patients without angina: use of an exercise score and exercise echocardiography. Eur Heart J 24 (2003) 1223-1230
65. Yao S.S., Qureshi E., Sherrid M.V., and Chaudhry F.A. Practical applications in stress echocardiography: risk stratification and prognosis in patients with known or suspected ischemic heart disease. J Am Coll Cardiol 42 (2003) 1084-1090
66. Kwok J.M., Christian T.F., Miller T.D., Hodge D.O., and Gibbons R.J. Incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium 201 imaging in patients with ST-T abnormalities on their resting electrocardiograms. Am Heart J 149 (2005) 145-151
67. Petix N.R., Sestini S., Coppola A., et al. Prognostic value of combined perfusion and function by stress technetium-99m sestamibi gated SPECT myocardial perfusion imaging in patients with suspected or known coronary artery disease. Am J Cardiol 95 (2005) 1351-1357
68. Petix N.R., Sestini S., Marcucci G., et al. Can the reversible regional wall motion abnormalities on stress gated Tc-99m sestamibi SPECT predict a future cardiac event?. J Nucl Cardiol 12 (2005) 20-31
69. Lombardi F., Tundo F., Terranova P., et al. Prognostic value of C-reactive protein in patients with stress induced myocardial ischemia. Int J Cardiol 98 (2005) 313-317
70. Liao L., Smith IV W.T., Tuttle R.H., Shaw L.K., Coleman R.E., and Borges-Neto S. Prediction of death and nonfatal myocardial infarction in high-risk patients: a comparison between the Duke treadmill score, peak exercise radionuclide angiography, and SPECT perfusion imaging. J Nucl Med 46 (2005) 5-11
71. Shaw L.J., Hendel R.C., Cerquiera M., et al. Ethnic differences in the prognostic value of stress technetium-99m tetrofosmin gated single-photon emission computed tomography myocardial perfusion imaging. J Am Coll Cardiol 45 (2005) 1494-1504
72. Elhendy A., Schinkel A.F., Van Domburg R.T., Bax J.J., and Poldermans D. Prediction of cardiac death in hypertensive patients with suspected or known coronary artery disease by stress technetium-99m tetrofosmin myocardial perfusion imaging. J Hypertens 21 (2003) 1945-1951
73. Borges-Neto S., Tuttle R.H., Shaw L.K., et al. Outcome prediction in patients at high risk for coronary artery disease: comparison between 99mTc tetrofosmin and 99mTc sestamibi. Radiology 232 (2004) 58-65
74. Krivokapich J., Child J.S., Gerber R.S., Lem V., and Moser D. Prognostic usefulness of positive or negative exercise stress echocardiography for predicting coronary events in ensuing twelve months. Am J Cardiol 71 (1993) 646-651
75. Shaw L.J., Hendel R., Borges-Neto S., et al. Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging: results from the multicenter registry of 4,728 patients. J Nucl Med 44 (2003) 134-139
76. Colon III P.J., Mobarek S.K., Milani R.V., et al. Prognostic value of stress echocardiography in the evaluation of atypical chest pain patients without known coronary artery disease. Am J Cardiol 81 (1998) 545-551
77. Gaddi O., Tortorella G., Picano E., et al. Diagnostic and prognostic value of vasodilator stress echocardiography in asymptomatic type 2 diabetic patients with positive exercise thallium scintigraphy: a pilot study. Diabet Med 16 (1999) 762-766
78. Blumenthal R.S., Becker D.M., Moy T.F., Coresh J., Wilder L.B., and Becker L.C. Exercise thallium tomography predicts future clinically manifest coronary heart disease in a high-risk asymptomatic population. Circulation 93 (1996) 915-923
79. Fagan Jr. L.F., Shaw L., Kong B.A., Caralis D.G., Wiens R.D., and Chaitman B.R. Prognostic value of exercise thallium scintigraphy in patients with good exercise tolerance and a normal or abnormal exercise electrocardiogram and suspected or confirmed coronary artery disease. Am J Cardiol 69 (1992) 607-611
80. Kaul S., Finkelstein D.M., Homma S., Leavitt M., Okada R.D., and Boucher C.A. Superiority of quantitative exercise thallium-201 variables in determining long-term prognosis in ambulatory patients with chest pain: a comparison with cardiac catheterization. J Am Coll Cardiol 12 (1988) 25-34
81. Kang X., Berman D.S., Lewin H.C., et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. Am Heart J 138 (1999) 1025-1032
82. Vanzetto G., Halimi S., Hammoud T., et al. Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography. Diabetes Care 22 (1999) 19-26
83. De Lorenzo A., Lima R.S., Siqueira-Filho A.G., and Pantoja M.R. Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am J Cardiol 90 (2002) 827-832
84. Colon III P.J., Guarisco J.S., Murgo J., and Cheirif J. Utility of stress echocardiography in the triage of patients with atypical chest pain from the emergency department. Am J Cardiol 82 (1998) 1282-1284
85. Borges-Neto S., Shaw L.K., Tuttle R.H., et al. Incremental prognostic power of single-photon emission computed tomographic myocardial perfusion imaging in patients with known or suspected coronary artery disease. Am J Cardiol 95 (2005) 182-188
86. Marie P.Y., Mercennier C., Danchin N., et al. Residual exercise SPECT ischemia on treatment is a main determinant of outcome in patients with coronary artery disease treated medically at long-term with beta-blockers. J Nucl Cardiol 10 (2003) 361-368
87. Zhang X., Liu X., He Z.X., et al. Long-term prognostic value of exercise 99mTc-MIBI SPECT myocardial perfusion imaging in patients after percutaneous coronary intervention. Eur J Nucl Med Mol Imaging 31 (2004) 655-662
88. L'Huillier I., Cottin Y., Touzery C., et al. Predictive value of myocardial tomoscintigraphy in asymptomatic diabetic patients after percutaneous coronary intervention. Int J Cardiol 90 (2003) 165-173
89. Elhendy A., Schinkel A.F., van Domburg R.T., Bax J.J., Valkema R., and Poldermans D. Prognostic value of stress Tc-99m tetrofosmin SPECT in patients with previous myocardial infarction: impact of scintigraphic extent of coronary artery disease. J Nucl Cardiol 11 (2004) 704-709
90. Elhendy A., Schinkel A.F., van Domburg R.T., Bax J.J., and Poldermans D. Differential prognostic significance of peri-infarction versus remote myocardial ischemia on stress technetium-99m sestamibi tomography in patients with healed myocardial infarction. Am J Cardiol 94 (2004) 289-293
91. Elhendy A., Schinkel A.F., van Domburg R.T., Bax J.J., Valkema R., and Poldermans D. Risk stratification of patients after myocardial revascularization by stress Tc-99m tetrofosmin myocardial perfusion tomography. J Nucl Cardiol 10 (2003) 615-622
92. Fesmire F.M., Hughes A.D., Stout P.K., Wojcik J.F., and Wharton D.R. Selective dual nuclear scanning in low-risk patients with chest pain to reliably identify and exclude acute coronary syndromes. Ann Emerg Med 38 (2001) 207-215
93. Gentile R., Vitarelli A., Schillaci O., et al. Diagnostic accuracy and prognostic implications of stress testing for coronary artery disease in the elderly. Ital Heart J 2 (2001) 539-545
94. Launbjerg J., Fruergaard P., Jacobsen H.L., Utne H.E., Reiber J., and Madsen J.K. The long-term predictive value of an exercise thallium-201 scintigraphy for patients with acute chest pain but without myocardial infarction. Coron Artery Dis 4 (1993) 195-200
95. Ben-Gal T., and Zafrir N. The utility and potential cost-effectiveness of stress myocardial perfusion thallium SPECT imaging in hospitalized patients with chest pain and normal or non-diagnostic electrocardiogram. Isr Med Assoc J 3 (2001) 725-730
96. Buchsbaum M., Marshall E., Levine B., et al. Emergency department evaluation of chest pain using exercise stress echocardiography. Acad Emerg Med 8 (2001) 196-199
97. Arruda A.M., Das M.K., Roger V.L., Klarich K.W., Mahoney D.W., and Pellikka P.A. Prognostic value of exercise echocardiography in 2,632 patients ≥65 years of age. J Am Coll Cardiol 37 (2001) 1036-1041
98. Kwok J.M., Christian T.F., Miller T.D., Hodge D.O., and Gibbons R.J. Identification of severe coronary artery disease in patients with a single abnormal coronary territory on exercise thallium-201 imaging: the importance of clinical and exercise variables. J Am Coll Cardiol 35 (2000) 335-344
99. Pavin D., Delonca J., Siegenthaler M., Doat M., Rutishauser W., and Righetti A. Long-term (10 years) prognostic value of a normal thallium-201 myocardial exercise scintigraphy in patients with coronary artery disease documented by angiography. Eur Heart J 18 (1997) 69-77
100. Parisi A.F., Hartigan P.M., and Folland E.D. Evaluation of exercise thallium scintigraphy versus exercise electrocardiography in predicting survival outcomes and morbid cardiac events in patients with single- and double-vessel disease. Findings from the Angioplasty Compared to Medicine (ACME) study. J Am Coll Cardiol 30 (1997) 1256-1263
101. Hendler A.L., Greyson N.D., Robinson M.G., and Freeman M.R. Patients with symptomatic ischemia have larger thallium perfusion abnormalities and more adverse prognosis than patients with silent ischemia. Can J Cardiol 8 (1992) 814-818
102. Brown K.A., Rowen M., and Altland E. Prognosis of patients with an isolated fixed thallium-201 defect and no prior myocardial infarction. Am J Cardiol 72 (1993) 1199-1201
103. Amanullah A.M., Heo J., and Iskandrian A.E. Impact of exercise single-photon emission computed tomographic imaging on appropriateness of coronary revascularization. Am J Cardiol 81 (1998) 1489-1491
104. Travin M.I., Boucher C.A., Newell J.B., LaRaia P.J., Flores A.R., and Eagle K.A. Variables associated with a poor prognosis in patients with an ischemic thallium-201 exercise test. Am Heart J 125 (1993) 335-344
105. Moriel M., Rozanski A., Klein J., Berman D.S., and Merz C.N. The limited efficacy of exercise radionuclide ventriculography in assessing prognosis of women with coronary artery disease. Am J Cardiol 76 (1995) 1030-1035
106. Hayashi K., Ohsuzu F., Kosuda S., and Nakamura H. Prediction of 6-year prognosis for cardiac event by thallium-201 single-photon emission computed tomography (SPECT) with treadmill exercise test. (in Japanese). Kaku Igaku 34 (1997) 443-451
107. Abdel Fattah A., Kamal A.M., Pancholy S., et al. Prognostic implications of normal exercise tomographic thallium images in patients with angiographic evidence of significant coronary artery disease. Am J Cardiol 74 (1994) 769-771
108. Kipper M.S., Labarbera J.J., and Krohn L.D. The 24-hour Tl-201 image in dual isotope myocardial perfusion scintigraphy: clinical utility and prognostic significance. Clin Nucl Med 23 (1998) 576-581
109. Candell-Riera J., Santana-Boado C., Bermejo B., et al. Prognosis of "clandestine" myocardial ischemia, silent myocardial ischemia, and angina pectoris in medically treated patients. Am J Cardiol 82 (1998) 1333-1338
110. Krishnan R., Lu J., Dae M.W., and Botvinick E.H. Does myocardial perfusion scintigraphy demonstrate clinical usefulness in patients with markedly positive exercise tests?. An assessment of the method in a high-risk subset. Am Heart J 127 (1994) 804-816
111. Santana-Boado C., Figueras J., Candell-Riera J., et al. Prognosis of patients with angina pectoris or silent ischemia: exercise 99mTC-MIBI SPECT. (in Spanish). Rev Esp Cardiol 51 (1998) 297-301
112. Elhendy A., Schinkel A.F., van Domburg R.T., Bax J.J., and Poldermans D. Prognostic significance of fixed perfusion abnormalities on stress technetium-99m sestamibi single-photon emission computed tomography in patients without known coronary artery disease. Am J Cardiol 92 (2003) 1165-1170
113. Machecourt J., Longere P., Mansour P., et al. Evaluation of prognosis and myocardial ischemia using thallium in myocardial tomoscintigraphy. (in French). Arch Mal Coeur Vaiss 86 (1993) 51-55
114. Hachamovitch R., Hayes S.W., Friedman J.D., Cohen I., and Berman D.S. Stress myocardial perfusion single-photon emission computed tomography is clinically effective and cost effective in risk stratification of patients with a high likelihood of coronary artery disease (CAD) but no known CAD. J Am Coll Cardiol 43 (2004) 200-208
115. Elhendy A., Mahoney D.W., Khandheria B.K., Paterick T.E., Burger K.N., and Pellikka P.A. Prognostic significance of the location of wall motion abnormalities during exercise echocardiography. J Am Coll Cardiol 40 (2002) 1623-1629
116. Elhendy A., Shub C., McCully R.B., Mahoney D.W., Burger K.N., and Pellikka P.A. Exercise echocardiography for the prognostic stratification of patients with low pretest probability of coronary artery disease. Am J Med 111 (2001) 18-23
117. Elhendy A. Prognostic stratification of diabetic patients by exercise echocardiography. J Am Coll Cardiol 37 (2001) 1551-1557
118. Elhendy A., Modesto K.M., Mahoney D.W., Khandheria B.K., Sweard J.B., and Pellikka P.A. Prediction of mortality in patients with left ventricular hypertrophy by clinical, exercise stress, and echocardiographic data. J Am Coll Cardiol 41 (2003) 129-135
119. McCully R.B., Roger V.L., Mahoney D.W., et al. Outcome after normal exercise echocardiography and predictors of subsequent cardiac events: follow-up of 1,325 patients. J Am Coll Cardiol 31 (1998) 144-149
120. Chatziioannou S.N., Moore W.H., Dhekne R.D., and Ford P.V. Women with high exercise tolerance and the role of myocardial perfusion imaging. Clin Cardiol 24 (2001) 475-480
121. Kaminek M., Myslivecek M., Skvarilova M., et al. Increased prognostic value of combined myocardial perfusion SPECT imaging and the quantification of lung Tl-201 uptake. Clin Nucl Med 27 (2002) 255-260
122. Berman D.S., Hachamovitch R., Kiat H., et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 26 (1995) 639-647
123. Berman D.S., Kang X., Van Train K.F., et al. Comparative prognostic value of automatic quantitative analysis versus semiquantitative visual analysis of exercise myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 32 (1998) 1987-1995
124. Iskandrian A.S., Johnson J., Le T.T., Wasserleben V., Cave V., and Heo J. Comparison of the treadmill exercise score and single-photon emission computed tomographic thallium imaging in risk assessment. J Nucl Cardiol 1 (1994) 144-149
125. Nozawa M., Tamaki N., Sugihara H., et al. Value of stress-rest ECG gated SPECT one day protocol using 99mTc-MIBI. (in Japanese). Kaku Igaku 32 (1995) 1363-1368
126. Gibbons R.J., Hodge D.O., Berman D.S., et al. Long-term outcome of patients with intermediate-risk exercise electrocardiograms who do not have myocardial perfusion defects on radionuclide imaging. Circulation 100 (1999) 2140-2145
127. Nallamouthu N., Araujo L., Russell J., Heo J., and Iskandrian A.E. Prognostic value of simultaneous perfusion and function assessment using technetium-99m sestamibi. Am J Cardiol 78 (1996) 562-564
128. Pancholy S.B., Fattah A.A., Kamal A.M., Ghods M., Heo J., and Iskandrian A.S. Independent and incremental prognostic value of exercise thallium single-photon emission computed tomographic imaging in women. J Nucl Cardiol 2 (1995) 110-116
129. Schalet B.D., Kegel J.G., Heo J., Segal B.L., and Iskandrian A.S. Prognostic implications of normal exercise SPECT thallium images in patients with strongly positive exercise electrocardiograms. Am J Cardiol 72 (1993) 1201-1203
130. Hachamovitch R., Berman D.S., Kiat H., et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 93 (1996) 905-914
131. Hachamovitch R., Berman D.S., Shaw L.J., et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 97 (1998) 535-543
132. Hachamovitch R., Berman D.S., Kiat H., Cohen I., Friedman J.D., and Shaw L.J. Value of stress myocardial perfusion single photon emission computed tomography in patients with normal resting electrocardiograms: an evaluation of incremental prognostic value and cost-effectiveness. Circulation 105 (2002) 823-829
133. Brown K.A., and Rowen M. Impact of antianginal medications, peak heart rate and stress level on the prognostic value of a normal exercise myocardial perfusion imaging study. J Nucl Med 34 (1993) 1467-1471
134. Brown K.A., and Rowen M. Prognostic value of a normal exercise myocardial perfusion imaging study in patients with angiographically significant coronary artery disease. Am J Cardiol 71 (1993) 865-867
135. Brown K.A., Altland E., and Rowen M. Prognostic value of normal technetium-99m-sestamibi cardiac imaging. J Nucl Med 35 (1994) 554-557
136. Hilton T.C., Shaw L.J., Chaitman B.R., Stocke K.S., Goodgold H.M., and Miller D.D. Prognostic significance of exercise thallium-201 testing in patients aged greater than or equal to 70 years with known or suspected coronary artery disease. Am J Cardiol 69 (1992) 45-50
137. Oosterhuis W.P., Breeman A., Niemeyer M.G., et al. Patients with a normal exercise thallium-201 myocardial scintigram: always a good prognosis?. Eur J Nucl Med 20 (1993) 151-158
138. Zanco P., Zampiero A., Favero A., et al. Myocardial technetium-99m sestamibi single-photon emission tomography as a prognostic tool in coronary artery disease: multivariate analysis in a long-term prospective study. Eur J Nucl Med 22 (1995) 1023-1028
139. Hoque A., Maaieh M., Longaker R.A., and Stoddard M.F. Exercise echocardiography and thallium-201 single-photon emission computed tomography stress test for 5- and 10-year prognosis of mortality and specific cardiac events. J Am Soc Echocardiogr 15 (2002) 1326-1334
140. Arruda-Olson A.M., Juracan E.M., Mahoney D.W., McCully R.B., Roger V.L., and Pellika P.A. Prognostic value of exercise echocardiography in 5,798 patients: is there a gender difference?. J Am Coll Cardiol 39 (2002) 625-631
141. Boyne T.S., Koplan B.A., Parsons W.J., Smith W.H., Watson D.D., and Beller G.A. Predicting adverse outcome with exercise SPECT technetium-99m sestamibi imaging in patients with suspected or known coronary artery disease. Am J Cardiol 79 (1997) 270-274
142. Chatziioannou S.N., Moore W.H., Ford P.V., et al. Prognostic value of myocardial perfusion imaging in patients with high exercise tolerance. Circulation 99 (1999) 867-872
143. del Val Gomez M., Gallardo F.G., Salazar M.L., and Terol I. Prognostic value of normal myocardial radionuclide scan in patients with positive treadmill test. (in Spanish). Rev Esp Cardiol 55 (2002) 991-994
144. Galassi A.R., Azzarelli S., Tomaselli A., et al. Incremental prognostic value of technetium-99m-tetrofosmin exercise myocardial perfusion imaging for predicting outcomes in patients with suspected or known coronary artery disease. Am J Cardiol 88 (2001) 101-106
145. Kaminek M., Myslivecek M., Skvarilova M., et al. Prognostic significance of stress tomographic scintigraphy of myocardial perfusion in diabetic patients. (in Czech). Vnitr Lek 47 (2001) 739-743
146. Zerahn B., Jensen B.V., Nielsen K.D., and Moller S. Increased prognostic value of combined myocardial perfusion imaging and exercise electrocardiography in patients with coronary artery disease. J Nucl Cardiol 7 (2000) 616-622
147. Vanzetto G., Ormezzano O., Fagret D., Comet M., Denis B., and Machecourt J. Long-term additive prognostic value of thallium-201 myocardial perfusion imaging over clinical and exercise stress test in low to intermediate risk patients: study in 1137 patients with 6-year follow-up. Circulation 100 (1999) 1521-1527
148. Sugihara H., Tamaki N., Mitsunami K., and Kinoshita M. Prognostic value of 1-day stress/rest electrocardiogram-gated single-photon emission computed tomography using Tc-99m-labeled methoxy-isobutyl isonitrile. Jpn Circ J 62 (1998) 405-408
149. Stratmann H.G., Williams G.A., Wittry M.D., Chaitman B.R., and Miller D.D. Exercise technetium-99m sestamibi tomography for cardiac risk stratification of patients with stable chest pain. Circulation 89 (1994) 615-622
150. Soman P., Parsons A., Lahiri N., and Lahiri A. The prognostic value of a normal Tc-99m sestamibi SPECT study in suspected coronary artery disease. J Nucl Cardiol 6 (1999) 252-256
151. Schinkel A.F., Elhendy A., van Domburg R.T., et al. Incremental value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography for the prediction of cardiac events. Am J Cardiol 91 (2003) 408-411
152. Raiker K., Sinusas A.J., Wackers F.J., and Zaret B.L. One-year prognosis of patients with normal planar or single-photon emission computed tomographic technetium 99m-labeled sestamibi exercise imaging. J Nucl Cardiol 1 (1994) 449-456
153. Pattillo R.W., Fuchs S., Johnson J., et al. Predictors of prognosis by quantitative assessment of coronary angiography, single photon emission computed tomography thallium imaging, and treadmill exercise testing. Am Heart J 131 (1996) 582-590
154. Olmos L.I., Dakik H., Gordon R., et al. Long-term prognostic value of exercise echocardiography compared with exercise 201Tl, ECG, and clinical variables in patients evaluated for coronary artery disease. Circulation 98 (1998) 2679-2686
155. Hachamovitch R., Hayes S., Friedman J.D., et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: what is the warranty period of a normal scan?. J Am Coll Cardiol 41 (2003) 1329-1340
156. Elhendy A., Schinkel A., Bax J.J., van Domburg R.T., and Poldermans D. Long-term prognosis after a normal exercise stress Tc-99m sestamibi SPECT study. J Nucl Cardiol 10 (2003) 261-266
157. Ambrosi P., Bruneau P., Faugere G., et al. Prognostic value of thallium-201 myocardial scintigraphy in patients with hypertension, suspected of coronary disease. (in French). Ann Cardiol Angeiol (Paris) 42 (1993) 479-483
158. Sawada S.G., Ryan T., Conley M.J., Corya B.C., Feigenbaum H., and Armstrong W.F. Prognostic value of a normal exercise echocardiogram. Am Heart J 120 (1990) 49-55
159. Ismail G., Lo E., Sada M., Conant R.D., Shapiro S.M., and Ginzton L.E. Long-term prognosis of patients with a normal exercise echocardiogram and clinical suspicion of myocardial ischemia. Am J Cardiol 75 (1995) 934-936
160. Hachamovitch R., Shaw L., and Berman D.S. Methodological considerations in the assessment of noninvasive testing using outcomes research: pitfalls and limitations. Prog Cardiovasc Dis 43 (2000) 215-230
161. Grady D., Chaput L., and Kristof M. Diagnosis and Treatment of Coronary Heart Disease in Women: Systematic Reviews of Evidence on Selected Topics (2003), Agency for Healthcare Research and Quality, Rockville, MD Evidence Report/Technology Assessment No. 81. (Prepared by the University of California, San Francisco-Stanford Evidence-based Practice Center under Contract No 290-97-0013.) AHRQ Publication No. 03-E037.
162. American Heart Association. Heart Disease and Stroke Statistics-2004 Update (2003), American Heart Association, Dallas, TX
163. Mulherin S.A., and Miller W.C. Spectrum bias or spectrum effect?. Subgroup variation in diagnostic test evaluation. Ann Intern Med 137 (2002) 598-602
164. Aktas M.K., Ozduran V., Pothier C.E., Lang R., and Lauer M.S. Global risk scores and exercise testing for predicting all-cause mortality in a preventive medicine program. JAMA 292 (2004) 1462-1468
165. Mora S., Redberg R.F., Cui Y., et al. Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence study. JAMA 290 (2003) 1600-1607
166. Lauer M.S. Is heart rate recovery a modifiable risk factor?. J Cardiopulm Rehabil 23 (2003) 88-89
167. Cheng Y.J., Lauer M.S., Earnest C.P., et al. Heart rate recovery following maximal exercise testing as a predictor of cardiovascular disease and all-cause mortality in men with diabetes. Diabetes Care 26 (2003) 2052-2057
168. Abidov A., Bax J.J., Hayes S.W., et al. Transient ischemic dilation ratio of the left ventricle is a significant predictor of future cardiac events in patients with otherwise normal myocardial perfusion SPECT. J Am Coll Cardiol 42 (2003) 1818-1825
169. Matsuo S., Matsumoto T., Nakae I., et al. Prognostic value of ECG-gated thallium-201 single-photon emission tomography in patients with coronary artery disease. Ann Nucl Med 18 (2004) 617-622